Moderna, Inc. — Director's Dealing 2019

Dec 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2019-12-10

Reporting Person: Nader Francois (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-10	Stock Option (Right to Buy)	$18.87	A	39720	Acquired	2029-12-10	Common Stock (39720)	Direct
2019-12-10	Stock Option (Right to Buy)	$18.87	A	17889	Acquired	2029-12-10	Common Stock (17889)	Direct

Footnotes

F1: This option will be fully vested and exercisable on December 10, 2020.

F2: This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service.